194 related articles for article (PubMed ID: 33373871)
1. Bridging the Age Gap in breast cancer: Impact of chemotherapy on quality of life in older women with early breast cancer.
Battisti NML; Reed MWR; Herbert E; Morgan JL; Collins KA; Ward SE; Holmes GR; Bradburn M; Walters SJ; Burton M; Lifford K; Edwards A; Robinson TG; Martin C; Chater T; Pemberton KJ; Shrestha A; Brennan A; Cheung KL; Todd A; Audisio RA; Wright J; Simcock R; Green T; Revell D; Gath J; Horgan K; Holcombe C; Winter MC; Naik J; Parmeshwar R; Gosney MA; Hatton MQ; Thompson AM; Wyld L; Ring A;
Eur J Cancer; 2021 Feb; 144():269-280. PubMed ID: 33373871
[TBL] [Abstract][Full Text] [Related]
2. Relationship between food perceptions and health-related quality of life in a prospective study with breast cancer patients undergoing chemotherapy.
Marinho EDC; Custódio IDD; Ferreira IB; Crispim CA; Paiva CE; Maia YCP
Clinics (Sao Paulo); 2018 Nov; 73():e411. PubMed ID: 30517281
[TBL] [Abstract][Full Text] [Related]
3. Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial.
Velikova G; Morden JP; Haviland JS; Emery C; Barrett-Lee P; Earl H; Bloomfield D; Brunt AM; Canney P; Coleman R; Verrill M; Wardley A; Bertelli G; Ellis P; Stein R; Bliss JM; Cameron D;
Lancet Oncol; 2023 Dec; 24(12):1359-1374. PubMed ID: 37926100
[TBL] [Abstract][Full Text] [Related]
4. Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial.
Perrone F; Nuzzo F; Di Rella F; Gravina A; Iodice G; Labonia V; Landi G; Pacilio C; Rossi E; De Laurentiis M; D'Aiuto M; Botti G; Forestieri V; Lauria R; De Placido S; Tinessa V; Daniele B; Gori S; Colantuoni G; Barni S; Riccardi F; De Maio E; Montanino A; Morabito A; Daniele G; Di Maio M; Piccirillo MC; Signoriello S; Gallo C; de Matteis A
Ann Oncol; 2015 Apr; 26(4):675-682. PubMed ID: 25488686
[TBL] [Abstract][Full Text] [Related]
5. Impact of pembrolizumab versus chemotherapy on health-related quality of life in patients with metastatic triple-negative breast cancer: results from the phase 3 randomised KEYNOTE-119 study.
Schmid P; Lipatov O; Im SA; Goncalves A; Muñoz-Couselo E; Lee KS; Tamura K; Testa L; Witzel I; Ohtani S; Turner N; Zambelli S; Harbeck N; Andre F; Dent R; Mejia JA; Zhou X; Haiderali A; Nguyen AM; Cortes J; Winer EP
Eur J Cancer; 2023 Dec; 195():113393. PubMed ID: 37976633
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
7. Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907.
Kornblith AB; Lan L; Archer L; Partridge A; Kimmick G; Hudis C; Winer E; Casey R; Bennett S; Cohen HJ; Muss HB
J Clin Oncol; 2011 Mar; 29(8):1022-8. PubMed ID: 21300923
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life in patients with breast cancer surgery and undergoing chemotherapy in Ahmednagar district.
Kshirsagar AS; Wani SK
J Cancer Res Ther; 2021; 17(6):1335-1338. PubMed ID: 34916362
[TBL] [Abstract][Full Text] [Related]
9. Bridging the age gap in breast cancer: impact of omission of breast cancer surgery in older women with oestrogen receptor-positive early breast cancer on quality-of-life outcomes.
Morgan JL; Shrestha A; Reed MWR; Herbert E; Bradburn M; Walters SJ; Martin C; Collins K; Ward S; Holmes G; Burton M; Lifford K; Edwards A; Ring A; Robinson T; Chater T; Pemberton K; Brennan A; Cheung KL; Todd A; Audisio R; Wright J; Simcock R; Thomson AM; Gosney M; Hatton M; Green T; Revill D; Gath J; Horgan K; Holcombe C; Winter MC; Naik J; Parmeschwar R; Wyld L
Br J Surg; 2021 Apr; 108(3):315-325. PubMed ID: 33760065
[TBL] [Abstract][Full Text] [Related]
10. Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer.
Brandberg Y; Johansson H; Hellström M; Gnant M; Möbus V; Greil R; Foukakis T; Bergh J;
Breast Cancer Res Treat; 2020 May; 181(1):87-96. PubMed ID: 32232698
[TBL] [Abstract][Full Text] [Related]
11. Bridging The Age Gap: observational cohort study of effects of chemotherapy and trastuzumab on recurrence, survival and quality of life in older women with early breast cancer.
Ring A; Battisti NML; Reed MWR; Herbert E; Morgan JL; Bradburn M; Walters SJ; Collins KA; Ward SE; Holmes GR; Burton M; Lifford K; Edwards A; Robinson TG; Martin C; Chater T; Pemberton KJ; Brennan A; Cheung KL; Todd A; Audisio RA; Wright J; Simcock R; Green T; Revell D; Gath J; Horgan K; Holcombe C; Winter MC; Naik J; Parmeshwar R; Gosney MA; Hatton MQ; Thompson AM; Wyld L;
Br J Cancer; 2021 Jul; 125(2):209-219. PubMed ID: 33972747
[TBL] [Abstract][Full Text] [Related]
12. Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after.
Miret C; Orive M; Sala M; García-Gutiérrez S; Sarasqueta C; Legarreta MJ; Redondo M; Rivero A; Castells X; Quintana JM; Garin O; Ferrer M;
Qual Life Res; 2023 Apr; 32(4):989-1003. PubMed ID: 36630024
[TBL] [Abstract][Full Text] [Related]
13. Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial.
Galle PR; Finn RS; Qin S; Ikeda M; Zhu AX; Kim TY; Kudo M; Breder V; Merle P; Kaseb A; Li D; Mulla S; Verret W; Xu DZ; Hernandez S; Ding B; Liu J; Huang C; Lim HY; Cheng AL; Ducreux M
Lancet Oncol; 2021 Jul; 22(7):991-1001. PubMed ID: 34051880
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in women treated with chemotherapy for breast cancer in Cali, Colombia.
Mejía-Rojas ME; Contreras-Rengifo A; Hernández-Carrillo M
Biomedica; 2020 Jun; 40(2):349-361. PubMed ID: 32673462
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
[TBL] [Abstract][Full Text] [Related]
16. Robotic Stereotactic Boost in Early Breast Cancer, a Phase 2 Trial.
Bondiau PY; Gal J; Chapellier C; Haudebourg J; Courdi A; Levy J; Gerard A; Sumodhee S; Maurin M; Château Y; Barranger E; Ferrero JM; Thariat J
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):374-380. PubMed ID: 30612961
[TBL] [Abstract][Full Text] [Related]
17. Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION): a multicentre, randomised, controlled, phase 2 trial.
Jones RH; Casbard A; Carucci M; Cox C; Butler R; Alchami F; Madden TA; Bale C; Bezecny P; Joffe J; Moon S; Twelves C; Venkitaraman R; Waters S; Foxley A; Howell SJ
Lancet Oncol; 2020 Mar; 21(3):345-357. PubMed ID: 32035020
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
[TBL] [Abstract][Full Text] [Related]
19. The impact of age on Health-Related Quality of Life (HRQoL) and symptoms among postmenopausal women with breast cancer receiving adjuvant chemotherapy.
Browall MM; Ahlberg KM; Persson LO; Karlsson PO; Danielson EB
Acta Oncol; 2008; 47(2):207-15. PubMed ID: 18210297
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
